Development of a Mesothelin-Binding Engineered Scaffold Protein as a Theranostic for Pleural Mesothelioma
Sign Up to like & getrecommendations! Published in 2025 at "Bioconjugate Chemistry"
DOI: 10.1021/acs.bioconjchem.5c00425
Abstract: Mesothelin (MSLN) is a tumor biomarker expressed at high levels on the surface of numerous cancers with extremely limited expression in healthy tissues. MSLN-targeting agents developed for diagnosis and therapy could have a significant impact… read more here.
Keywords: binding fn3; msln; protein; pleural mesothelioma ... See more keywords